Results 241 to 250 of about 79,213 (303)

COMIT-ANZ: an audit of cholangiocarcinoma and mixed hepatocellular carcinoma-cholangiocarcinoma outcomes for patients undergoing liver transplantation in Australia and New Zealand. [PDF]

Front Transplant
Riddiough GE, Hall K, Byrne M, Brown K, Kilburn D, Goh SK, Marshall-Webb M, Pulitano C, Chan K, Philipoff A, Nazaar A, Lee E.   +11 more
europepmc   +1 more source

Natural Product‐Induced Ferroptosis to Overcome Therapy Resistance in Aggressive Cancers

ChemMedChem, Volume 21, Issue 20, 28 October 2026.
Natural products trigger ferroptosis through iron overload, glutathione depletion, glutathione peroxidase 4 inhibition, and reactive oxygen species accumulation, selectively targeting aggressive, and drug‐resistant cancers. Polyphenols, alkaloids and terpenoids emerge as promising multi‐target agents to overcome therapy resistance and improve future ...
Giorgio Antoniolli
wiley   +1 more source

Massive pleural effusion due to transdiaphragmatic extension of intrahepatic cholangiocarcinoma. [PDF]

BMJ Case Rep
Ogata T, Kamitsuma C, Kirimura S, Yamashita T.   +3 more
europepmc   +1 more source

Evaluation of early C‐reactive protein kinetics as an early response marker in biliary tract cancer treated with combined chemoimmunotherapy: A multicenter observational study

Cancer, Volume 132, Issue 20, 15 October 2026.
Abstract Background Reliable prognostic biomarkers for treatment response in patients with biliary tract cancer (BTC) who receive chemoimmunotherapy are still lacking. The objective of this study was to evaluate the potential of early C‐reactive protein (CRP) kinetics as a tool for predicting survival in these patients.
Gabriel Allo, Joshua Leutiger, Catherine Leyh, Christian Möhring, Ann‐Kristin Zöller, Vera Himmelsbach, Gianluca Ciarlo, Maryam Barsch, Christoph Neumann‐Haefelin, Bertram Bengsch, Fabian Finkelmeier, Mohamad Murad, Cennet Sahin, Marie‐Luise Berres, Maria A. Gonzalez‐Carmona, Christoph Roderburg, Arndt Weinmann, Anna Saborowski, Arndt Vogel, Dirk Waldschmidt   +19 more
wiley   +1 more source

Incidental/Misdiagnosed Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma in Patients Undergoing Living Donor Liver Transplantation. [PDF]

J Clin Med
Yilmaz TU, Özer A, Yildar M, Aktaş H, Bati B, Can MG, Sökmen BK, Kirimlioğlu H, Karakayali H.   +8 more
europepmc   +1 more source

Carbon dots in cancer therapy: a novel approach to targeted drug delivery and reduced toxicity in gallbladder cancer. [PDF]

Front Chem
Fatima M, Parveen W, Almaneai NM, El-Kott AF, AlShehri MA, Eltantawy W, Kanwal N, Saadia Z.   +7 more
europepmc   +1 more source

¹⁹²Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable hilar cholangiocarcinoma. [PDF]

Front Oncol
Yang W, Wang Y, Xiao L, Liu F, Zhou J, Sun Y.   +5 more
europepmc   +1 more source

The Cost of Uncertainty: A Microcosting Analysis of the Cancer of Unknown Primary Diagnostic Pathway. [PDF]

BJC Rep
Spurgeon L, Mitchell C, Conway AM, Cook N, Gavan SP.   +4 more
europepmc   +1 more source

Trends and disparities in intrahepatic cholangiocarcinoma mortality in the United States, 1999-2024: a CDC WONDER analysis. [PDF]

Front Oncol
Chen J, Yang G, Sun X.
europepmc   +1 more source

Targeting adaptive EGFR feedback enhances the therapeutic efficacy of RMC-6236 in cholangiocarcinoma. [PDF]

Exp Hematol Oncol
Yamazaki S, Hondo N, Yasukawa K, Kitazawa M, Nakamura S, Yamamoto Y, Miyazaki S, Tanaka H, Kuroiwa M, Ishizaka N, Shimizu T, Shimizu A, Soejima Y.   +12 more
europepmc   +1 more source